Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection (the SAMBA-D Study)

NCT07610772 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT07610772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection (the SAMBA-D Study)
Lead sponsor
Aarhus University Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
April 23, 2026
Completion date
April 1, 2028
Enrollment
15 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b chronic infection, hepatitis d, chronic